Stereoselective hepatic disposition of a diastereomeric pair of α_vβ₃ antagonists in rat

References

• AKITA, H., Suzum, H. and SUGIYAMA, Y., 2001, Sinusoidal efflux of taurocholate is enhanced in Mrp2-deficient rat liver. Pharmaceutical Research, 18, 1119–1125.
   PubMed Web of Science ®Google Scholar
• AYRTON, A. and MORGAN, P., 2001, Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica, 31, 469–497.
   PubMed Web of Science ®Google Scholar
• BRADFORD, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein—dye binding. Analytical Biochemistry, 72, 248–254.
   PubMed Web of Science ®Google Scholar
• FORD, J. M. and HAIT, W. H., 1990, Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacological Reviews, 42, 155-199. GEKELER, V., ISE, W., SANDERS, K. H., ULRICH, W.-R. and BECK, J., 1995, The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochemical and Biophysical Research Communications, 208, 345–352.
   Google Scholar
• HARTMAN, G. D. and DUGGAN, M. E., 2000, Alpha (v) beta (3) integrin antagonists as inhibitors of bone resorption. Expert Opinion on Investigational Drugs, 9, 1281–1291.
   PubMed Web of Science ®Google Scholar
• HIROHASHI, T., SUZUKI, H., ITo, K., OGAWA, K., KUME, K., SHIMIZU, T. and SUGIYAMA, Y., 1998, Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Molecular Pharmacology, 53, 1068–1075.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI, K., SOGAME, Y., HARA, H. and HAYASHI, K., 1990, Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. Journal of Biological Chemistry, 265, 7737–7741.
   PubMed Web of Science ®Google Scholar
• Kisimc, J., NIES, A. T., Cm, Y., LEIER, I. and KEPPLER, D., 1999a, Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochimica et Biophysica Acta, 1461, 377–394.
   PubMedGoogle Scholar
• K0NIG, J., ROST, Y., Cm, Y. and KEPPLER, D., 1999b, Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Journal of Biological Chemistry, 274, 15181–15185.
   Google Scholar
• KULLAK-UBLICK, G. A., BEUERS, U. and PAUMGARTNER, G, 2000, Hepatobiliary transport. Journal of Hepatology, 32 (suppl. 1), 3–18.
   PubMedGoogle Scholar
• LEIER, I., JEDLITSCHKY, G., BUCHHOLZ, U., CENTER, M., COLE, S. P. C., DEELEY, R. G. and KEPPLER, D., 1996, ATP-dependent glutathione disulfide transport mediated by the MRP gene-encoded conjugate export pump. Biochemical Journal, 314, 433–437.
   Google Scholar
• LIN, J. H., CHIBA, M., CHEN, I.-W., NISHIME, J. A., DELUNA, F. A., YAMAZAKI, M. and LIN, Y. J., 1999, Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: Evidence of cytochrome P-450A and P-glycoprotein induction. Drug Metabolism and Disposition, 27, 1187–1193.
   Google Scholar
• MEIER, P. J. and STIEGER, B., 2002, Bile salt transporters. Annual Review of Physiology, 64, 635–661.
   PubMed Web of Science ®Google Scholar
• MEIJER, D. K. F., SMIT, J. W. and MULLER, M., 1997, Hepatobiliary elimination of cationic drugs: the role of P-glycoprotein and other ATP-dependent transporters. Advanced Drug Delivery Reviews, 25, 159–200.
   Google Scholar
• PAYEN, L., COURTOIS, A., CAMPION, J.-P., GULLOUZO, A. and FARDEL, 0., 2000, Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes. Biochemical Pharmacology, 60, 1967–1975.
   Google Scholar
• PRUEKSARITANONT, T., MENG, Y., MA, B., LEPPERT, P., HOCHMAN, J., TANG, C., PERKINS, J., ZRADA, M., MEISSNER, R., DUGGAN, M. E. and LIN, J. H., 2002, Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of avb3 antagonists in rats: Limited role of P-glycoprotein. Xenobiotica, 32, 207–220.
   PubMed Web of Science ®Google Scholar
• SCHINKEL, A. H., WAGENAAR, E., MOL, C. A., VAN DEEMTER, L. and BORST, P., 1996, P-glycoprotein in the blood brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. Journal of Clinical Investigation, 97, 2517–2524.
   PubMed Web of Science ®Google Scholar
• SCHINKEL, A. H., WAGENAAR, E., VAN DEEMTER, L., MOL, C. A. and BORST, P., 1995, Absence of the mdrl a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A. Journal of Clinical Investigation, 96, 1698–1705.
   PubMed Web of Science ®Google Scholar
• SMIT, J. W., SCHINKEL, A. H., WEERT, B. and MEIJER, D. K. F., 1998, Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdrl a and mdrlb genes have been disrupted. British Journal of Pharmacology, 124, 416–424.
   PubMed Web of Science ®Google Scholar
• TAKENAKA, 0., HORIE, T., SUZUKI, H., KOBAYASHI, K. and SUGIYAMA, Y., 1995, Kinetic analysis of hepatobiliary transport for conjugative metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugative hyperbilirubinemia. Pharmaceutical Research, 12, 1746–1755.
   Google Scholar
• YAMAZAKI, M., AKIYAMA, S., NI'INUMA, K., NISHIGAKI, R. and SUGIYAMA, Y., 1997, Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispe-cific organic anion transporter (cMOAT). Drug Metabolism and Disposition, 25, 1123–1129.
   Google Scholar
• YAMAZAKI, M., KOBAYASHI, K. and SUGIYAMA, Y., 1996, Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats. Biopharmaceutics and Drug Disposition, 17, 607–621.
   PubMed Web of Science ®Google Scholar